Breaking Down American Financial Group, Inc. Financial Health: Key Insights for Investors

Curious whether American Financial Group (AFG) is a resilient insurer worth investors' attention? In Q1 2025 AFG reported total revenues of $1.86 billion, outperforming analyst expectations as higher net earned premiums offset weaker alternative investment returns; Q2 net operating earnings per share came in at $2.14, beating the Zacks Consensus by 2.9% despite a 16.4% year-over-year decline, while Q3 net EPS rose to $2.58 from $2.16 a year earlier; profitability metrics show volatility - core operating EPS slid to $1.81 in Q1 (down 34% YoY) but climbed to $2.69 in Q3 (up 16% YoY) - and annualized return on equity fell to 13.3% in Q1 2025 from 21.2% a year prior even as full‑year 2024 ROE reached 19.0%; underwriting remains a strength with Specialty P&C reporting a 93.1% combined ratio in Q2 2025, and capital allocation is active: AFG returned roughly $292 million to shareholders in Q1 (including $167 million special dividends and $58 million buybacks), declared a $2.00 per share special dividend in Q3, increased its common dividend by 10% in August 2025, and in September announced an offering of $350 million 5.0% Senior Notes due 2035 priced at 99.162% to support general corporate purposes and potential repurchases - book value per share (ex-AOCI) stood at $54.15 as of June 30, 2025, and net after-tax non‑core items trimmed Q3 net income by $0.11 per share (versus $0.15 in 2024), leaving several datapoints investors should weigh in the full analysis

American Financial Group, Inc. (AFGB) - Revenue Analysis

• Q1 2025: Total revenues $1.86 billion, above analyst expectations of $1.74 billion, driven primarily by higher net earned premiums despite weaker alternative investment returns.
• Q2 2025: Net operating earnings per share (EPS) $2.14, beating the Zacks Consensus Estimate by 2.9% but down 16.4% year-over-year due to reduced underwriting profit and lower alternative investment yields.
• Q3 2025: Net EPS $2.58 versus $2.16 in Q3 2024; net after-tax non-core items reduced net income by $0.11 per share in 2025 (compared with $0.15 in 2024).
• Q4 2024 (reported): Net EPS $3.03, core net operating EPS $3.12; full-year return on equity (ROE) was 19.0% for 2024.
• Q1 2025 (annualized): ROE 13.3%, down from 21.2% in Q1 2024, signaling lower profitability on equity.
• Q2 2025 (segment performance): Specialty P&C combined ratio 93.1%, indicating solid underwriting profitability despite challenging market conditions.

• Net earned premiums: primary contributor to revenue beats (notably Q1 2025).
• Alternative investments: lower returns have weighed on investment income and net operating earnings in 2025 quarters.
• Underwriting: Specialty P&C's combined ratio of 93.1% in Q2 2025 shows disciplined underwriting, partially offsetting investment weakness.
• Non-core items: modest after-tax impacts in Q3 2025 (-$0.11/sh) and Q3 2024 (-$0.15/sh) affected comparable net EPS.

American Financial Group, Inc. (AFGB) - Profitability Metrics

• Core EPS trajectory: Q4 2024 peak at $3.12, sharp drop in Q1 2025 to $1.81, partial recovery by Q3 2025 to $2.69.
• Investment-return sensitivity: swings in alternative investment returns materially impacted core earnings in Q1 and Q2 2025.
• Underwriting performance: Specialty P&C maintained underwriting profitability with a combined ratio of 93.1% in Q2 2025, helping offset weaker investment results.
• Return on equity: fell from ~21.2% (Q1 2024) to an annualized 13.3% in Q1 2025, signaling reduced capital efficiency during the period of weaker investment and underwriting results.

• Investors should monitor: quarterly core net operating EPS trends, alternative-investment yield/valuation signals, and combined ratios across P&C lines for evidence of sustained underwriting discipline.

American Financial Group, Inc. (AFGB) - Debt vs. Equity Structure

• Debt issuance: In September 2025 AFG priced $350 million of 5.0% Senior Notes due September 23, 2035 at 99.162% of par - net proceeds earmarked for general corporate purposes, including potential share repurchases.
• Shareholder returns: AFG returned approximately $292 million to shareholders in Q1 2025 (including $167 million in special dividends and $58 million in share repurchases), roughly $107 million in Q2 2025 (including $39 million in share repurchases), and declared a $2.00 per share special dividend in Q3 2025 (payable Nov 26, 2025).
• Dividend policy: In August 2025 AFG increased its annual common stock dividend by 10%, marking the twentieth consecutive year of dividend increases.
• Equity capital: As of June 30, 2025, book value per share (excluding accumulated other comprehensive income) was $54.15, signaling a solid equity base supporting both underwriting and capital return programs.

• Implications for leverage: The 10-year senior notes extend AFG's debt maturity profile at a fixed 5.0% coupon, modestly increasing funded debt while enabling liquidity for buybacks and dividends without immediate equity issuance.
• Capital allocation mix: Large special dividends and ongoing repurchases in 2025 indicate a tilt toward returning excess capital to shareholders while maintaining book value per share above $54 (ex-AOCI).
• Investor considerations: Fixed-rate long-term debt improves predictability of interest expense; continued dividends and repurchases support EPS and yield metrics but warrant monitoring of payout sustainability relative to underwriting performance and statutory surplus.

American Financial Group, Inc. (AFGB) - Liquidity and Solvency

American Financial Group, Inc. (AFGB) exhibits mixed signals across liquidity and solvency metrics through late 2024 and 2025. Key profitability drivers and underwriting performance influence cash flow generation and balance sheet strength, while non-core items and changing returns on equity highlight variability in capital efficiency.

• Return on equity: Q1 2025 annualized ROE 13.3% vs. Q1 2024 21.2% - a notable decline reflecting reduced profitability and potential pressure on internal capital generation.
• Underwriting profitability: Q2 2025 Specialty P&C combined ratio 93.1% - solid underwriting results that support reserve adequacy and underwriting margin despite market headwinds.
• Earnings per share: Q3 2025 EPS $2.58 vs. Q3 2024 $2.16; net after‑tax non‑core items reduced EPS by $0.11 in 2025 and $0.15 in 2024, indicating recurring adjustments to reported earnings.
• Full‑year 2024: Q4 2024 reported EPS $3.03 and core net operating EPS $3.12, with a 19.0% return on equity for the year - demonstrating prior-year capital returns above 2025 levels.

Capital adequacy considerations include the interplay between underwriting profit (combined ratio), investment returns, and one‑time/non‑core adjustments to earnings that affect retained surplus and solvency cushions. Liquidity sources such as investment portfolio cash flow, premium inflows, and reinsurance arrangements are implicitly supported by the 93.1% combined ratio in Specialty P&C for Q2 2025, while the declining ROE year‑over‑year signals a need to monitor capital deployment and dividend/share repurchase policy.

• Primary liquidity supports: investment income, premium receipts, reinsurance recoverables, and realized gains/losses.
• Primary solvency risks: lower ROE reducing retained earnings, volatility from non‑core items, and market / interest rate sensitivity across the investment portfolio.
• Key monitoring metrics for investors: combined ratio trends, ROE trajectory, core operating EPS vs. reported EPS, and magnitude/frequency of non‑core adjustments.

For AFG's broader corporate goals and guiding principles that contextualize capital allocation and risk appetite, see Mission Statement, Vision, & Core Values (2026) of American Financial Group, Inc. .

American Financial Group, Inc. (AFGB) - Valuation Analysis

• Book value per share (ex-AOCI): $54.15 as of June 30, 2025.
• Q2 2025 net operating earnings per share: $2.14 (2.9% above Zacks consensus; down 16.4% YoY).
• Q3 2025 net earnings per share: $2.58 vs. $2.16 in Q3 2024; net after-tax non-core items reduced EPS by $0.11 in 2025 and $0.15 in 2024.
• Q4 2024 net EPS: $3.03; core net operating EPS: $3.12; full-year ROE: 19.0% (FY 2024).
• Q1 2025 annualized ROE: 13.3% (down from 21.2% in Q1 2024).
• Q2 2025 Specialty P&C combined ratio: 93.1% (solid underwriting profitability under challenging conditions).

• The $54.15 book value per share provides a tangible-accounting floor for intrinsic-value assessments and supports price-to-book comparisons versus peers.
• Recent EPS volatility-net operating EPS down 16.4% YoY in Q2 2025 and lower annualized ROE in Q1 2025-signals near-term pressure from underwriting profits and alternative-investment returns, important when applying multi-period DCF or dividend-discount sensitivity scenarios.
• Q3 2025 sequential improvement in reported net EPS to $2.58, despite non-core item drag, suggests partial recovery dynamics that should be stress-tested in valuation models (scenario ranges for combined ratio and investment yields).
• The Specialty P&C combined ratio of 93.1% evidences continued underwriting discipline and is a favorable input for underwriting margin assumptions in sum-of-the-parts or excess-capital valuation approaches.

American Financial Group, Inc. (AFGB) - Risk Factors

• Declining profitability: annualized return on equity fell to 13.3% in Q1 2025 from 21.2% in Q1 2024, signaling reduced earnings efficiency and potential strain on retained capital.
• Underwriting volatility: Specialty P&C operations produced a combined ratio of 93.1% in Q2 2025 - solid underwriting profitability but still sensitive to catastrophe losses and reserve development.
• Earnings composition risk: Q3 2025 net EPS was $2.58 versus $2.16 in Q3 2024, but net after‑tax non‑core items subtracted $0.11 per share in 2025 (vs. $0.15 in 2024), showing that non-core items materially affect reported results.
• Historical ROE pressure: despite a 19.0% ROE for full-year 2024 (with Q4 2024 net EPS $3.03 and core net operating EPS $3.12), more recent annualized ROE deterioration raises questions about sustainability.
• Market and investment risk: lower ROE and earnings variability can reflect or cause shifts in investment income, asset allocation risk and sensitivity to rising interest rates or credit spreads.
• Liquidity and capital management: weaker profitability and episodic non‑core charges could constrain capital deployment for dividends, share repurchases or acquisitions.

• Reserve and loss-development risk: combined ratios below 100% are encouraging, but adverse development on prior reserves could reverse underwriting gains.
• Non‑core item sensitivity: recurring or lump‑sum non‑core adjustments materially affect reported EPS and investor perception.
• Capital allocation tradeoffs: management must balance dividend/share‑repurchase policy against rebuilding ROE and reserve adequacy.
• Macroeconomic & market risk: interest rate moves, credit spreads and equity-market volatility can amplify earnings swings and investment returns.

American Financial Group, Inc. (AFGB) - Growth Opportunities

• Profitability trend: annualized return on equity (ROE) fell to 13.3% in Q1 2025 from 21.2% in Q1 2024, signaling reduced profitability and potential liquidity/capital allocation impacts.
• Underwriting performance: Specialty P&C reported a combined ratio of 93.1% in Q2 2025, indicating underwriting profitability despite challenging market conditions.
• Earnings momentum: net EPS improved in certain periods - Q3 2025 EPS of $2.58 vs. $2.16 in Q3 2024 - though net after‑tax non‑core items reduced EPS by $0.11 in 2025 and $0.15 in 2024 for Q3.
• Full‑year strength: Q4 2024 net EPS was $3.03 and core net operating EPS was $3.12, with a reported 19.0% ROE for the full year, demonstrating capacity for strong returns when markets and operations align.

• Operational levers for growth:
  • Leverage Specialty P&C underwriting discipline (93.1% combined ratio in Q2 2025) to expand selective premium volumes without degrading margins.
  • Restore ROE through targeted capital redeployment, expense control, and optimizing investment yield given the drop from 21.2% (Q1 2024) to 13.3% (Q1 2025).
  • Reduce volatility from non‑core items and improve clarity on recurring core operating earnings to support valuation expansion.
• Investor considerations:
  • Monitor sequential ROE recovery and quarterly combined ratios for Specialty lines as leading indicators of sustainable earnings improvement.
  • Track core net operating EPS vs. GAAP EPS divergence (e.g., Q4 2024: core $3.12 vs. GAAP $3.03) to assess underlying operating trends.
  • Evaluate consistency of underwriting profitability across segments before expecting meaningful capital returns or dividend increases.